Entellus Medical Announces Proposed Public Offering of Common Stock
Jan 25, 2017 21:45 pm UTC| Business
PLYMOUTH, Minn., Jan. 25, 2017 -- Entellus Medical, Inc. (the “Company” or “Entellus Medical”) (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through...
Marathon Oil Corporation Declares Fourth Quarter 2016 Dividend
Jan 25, 2017 21:43 pm UTC| Business
HOUSTON, Jan. 25, 2017 -- Marathon Oil Corporation (NYSE: MRO) announced today that the Company's board of directors has declared a dividend of 5 cents per share on Marathon Oil Corporation common stock. The dividend is...
Evans Bancorp, Inc. Announces Closing of Partial Exercise of Overallotment Option
Jan 25, 2017 21:43 pm UTC| Business
HAMBURG, N.Y., Jan. 25, 2017 -- Evans Bancorp, Inc. (NYSE MKT:EVBN) (the “Company”), a community financial services company serving Western New York, today announced that it has completed the sale of an additional...
Avid Wins Two Prestigious TEC Awards at the 2017 NAMM Show
Jan 25, 2017 21:35 pm UTC| Business
BURLINGTON, Mass., Jan. 25, 2017 -- Avid® (Nasdaq:AVID) today announced that it won two technical achievement awards at the 32nd Annual NAMM Technical Excellence Creativity (TEC) Awards. Presented at the 2017 NAMM Show...
Jan 25, 2017 21:33 pm UTC| Business
SOUDERTON, Pa., Jan. 25, 2017 -- Univest Corporation of Pennsylvania (“Univest” or “Corporation”) (NASDAQ:UVSP), parent company of Univest Bank and Trust Co. ("Bank") and its insurance, investments and equipment...
Brookline Bancorp Announces Fourth Quarter Results
Jan 25, 2017 21:30 pm UTC| Business
BOSTON, Jan. 25, 2017 -- Brookline Bancorp, Inc. (NASDAQ:BRKL) (the “Company”) today announced net income of $13.3 million, or $0.19 per basic and diluted share, for the fourth quarter of 2016, compared to $13.3...
MacroGenics Announces Appointments to Board of Directors
Jan 25, 2017 21:30 pm UTC| Business
Rockville, MD, Jan. 25, 2017 -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of...